Antioxidants suppress Th1-type immune response in vitro

Drug Metab Lett. 2007 Aug;1(3):166-71. doi: 10.2174/187231207781369816.

Abstract

Inflammation is a hallmark of various diseases like infections, autoimmune syndromes, cardiovascular and neurodegenerative disorders, and cancer. Thereby, Th1-type cytokine interferon-gamma is a central pro-inflammatory mediator. Antioxidant compounds counteract the activation of T-cells and macrophages. This anti-inflammatory activity could be important for the development of immunotolerance and for treatment of above-mentioned disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Antioxidants / pharmacology*
  • Humans
  • Immune Tolerance / drug effects
  • Inflammation / drug therapy*
  • Inflammation / immunology
  • Interferon-gamma / immunology
  • Macrophages / drug effects
  • Macrophages / immunology
  • Plant Extracts / pharmacology
  • Th1 Cells / immunology*

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Plant Extracts
  • Interferon-gamma